Longpre Lara 4
4 · Mirum Pharmaceuticals, Inc. · Filed May 19, 2023
Insider Transaction Report
Form 4
Longpre Lara
Chief Development Officer
Transactions
- Award
Common Stock
2023-05-10$16.92/sh+684$11,576→ 106,843 total
Footnotes (1)
- [F1]This Form 4 is being filed voluntarily to report the acquisition of 684 shares by the Reporting Person on May 10, 2023 pursuant to the Issuer's Employee Stock Purchase Plan.